Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Direction of Auditory Pitch-Change Influences Visual Search for Slope From Graphs.

Parrott S, Guzman-Martinez E, Orte L, Grabowecky M, Huntington MD, Suzuki S.

Perception. 2015;44(7):764-78.

2.

[Strategies for renal health: a project of the Spanish Society of Nephrology].

Martínez Castelao A, Martín de Francisco A, Górriz J, Alcázar R, Orte L.

Nefrologia. 2009;29(3):185-92. doi: 10.3265/Nefrologia.2009.29.3.5326.en.full. Spanish. No abstract available.

3.

[SEN-SEMFYC consensus document on chronic kidney disease].

Alcázar R, Egocheaga MI, Orte L, Lobos JM, González Parra E, Alvarez Guisasola F, Górriz JL, Navarro JF, Martín de Francisco AL.

Nefrologia. 2008;28(3):273-82. Spanish. No abstract available.

4.

[Importance of very best outpatient management of patients with chronic renal disease].

Orte L, Gómez-Campderá F.

Nefrologia. 2006;26 Suppl 3:1-5. Spanish. No abstract available.

5.

[Efficiency of implementing a program aimed at achieving early referral to the nephrologist of patients with chronic renal failure in primary care].

Aguilar MD, Orte L, Lázaro P, Gómez-Campderá FJ, Fernández Giráldez E, Sanz Guajardo D, Pastor V; INESIR Group.

Nefrologia. 2006;26 Suppl 3:114-20. Spanish. No abstract available.

6.

[Presence of the nephrologist at the specialty outpatient clinic setting: successes, darkness and future after 13-year experince].

Fernández Lucas M, Orte L, Pascual J, Rivera M, Fernández Rodríguez A, Ortuño J.

Nefrologia. 2006;26 Suppl 3:82-7. Review. Spanish. No abstract available.

7.

[Quality of life in patients with chronic renal failure. Influence of nephrologist's early intervention and pre-dialysis clinical visit consultation].

Sanz Guajardo D, Orte L, Gómez-Campderá F, Fernández E, Aguilar MD, Lázaro P; INESIR Group.

Nefrologia. 2006;26 Suppl 3:56-65. Spanish. No abstract available.

8.

[Clinical status of the patient at the time of dialysis onset. INESIR study].

Gómez-Campderá FJ, Orte L, Aguilar MD, Fernández Giráldez E, Lázaro P, Sanz Guajardo D; INESIR Group.

Nefrologia. 2006;26 Suppl 3:12-8. Spanish. No abstract available.

9.

Long-term follow-up of tacrolimus treatment in immune posterior uveitis.

Figueroa MS, Ciancas E, Orte L.

Eur J Ophthalmol. 2007 Jan-Feb;17(1):69-74.

PMID:
17294385
10.

[Clinical research based nephrology (bases for the constitution of an Evidence Based Nephrology Group in the Spanish Society of Nephrology)].

Quereda C, Pascual J, García-López F, Alcázar R, Aljama P, Amenábar JJ, Arias M, Barrio V, Fernández-Rodríguez A, Fernández Juárez G, Fernández-Lucas M, Gallego N, Hernández D, Gómez-Alamillo C, Maduell F, Martínez Castelao A, Marcén R, Matesanz R, Martín de Francisco AL, Orte L, Liaño F, Luño J, Ortuño J, Pérez García R, Praga M, Saracho R, Selgas R, Rivera M, Rodríguez Pérez JC, Teruel JL, Tato A, Torres A, Valdés F.

Nefrologia. 2006;26(2):163-72. Review. Spanish. No abstract available.

11.

Effect of hypertension before beginning dialysis on survival of hemodialysis patients.

Lucas MF, Quereda C, Teruel JL, Orte L, Marcén R, Ortuño J.

Am J Kidney Dis. 2003 Apr;41(4):814-21. Review.

PMID:
12666068
12.

Renovascular hypertension in children.

Estepa R, Gallego N, Orte L, Puras E, Aracil E, Ortuño J.

Scand J Urol Nephrol. 2001 Oct;35(5):388-92.

PMID:
11771866
13.

Pediatric renovascular hypertension.

Estepa R, Gallego N, Orte L, Belanger A, Aracil E, Ortuño J.

Pediatr Nephrol. 2001 Jun;16(6):529-31. No abstract available.

PMID:
11420923
14.

Clinical characteristics of ischaemic renal disease.

Alcázar JM, Marín R, Gómez-Campderá F, Orte L, Rodríguez-Jornet A, Mora-Macía J; Spanish Group of Ischaemic Nephrology (GEDENI).

Nephrol Dial Transplant. 2001;16 Suppl 1:74-7.

PMID:
11369827
15.

[History of the Registry Committee of the Spanish Society of Nephrology].

Amenábar JJ, Barrio V, Botella J, García García M, García López F, López Pedret J, Olmos A, Orte L, Robles NR, Saracho R, Tejedor A, Vallés M; Comités del Registro de la Sociedad Española de Nefrología.

Nefrologia. 2000;20 Suppl 5:2-6. Spanish. No abstract available.

16.

Antiproteinuric effect of calcium antagonists on puromycin-induced experimental nephrosis.

Martin A, Cuevas B, Escudero E, Nieto E, Cuevas P, Pascual J, Ortuño J, Orte L, Mampaso F.

Ren Fail. 2000 Jan;22(1):17-26.

PMID:
10718277
17.

Fibroblast growth factor protects the kidney against ischemia-reperfusion injury.

Cuevas P, Martinez-Coso V, Fu X, Orte L, Reimers D, Giménez-Gallego G, Forssmann WG, Saenz De Tejada I.

Eur J Med Res. 1999 Oct 15;4(10):403-10.

PMID:
10527953
18.

Malignant pheochromocytoma, still a therapeutic challenge.

Tato A, Orte L, Diz P, Quereda C, Ortuno J.

Am J Hypertens. 1997 Apr;10(4 Pt 1):479-81.

PMID:
9128218
19.

Urinary calcium excretion in treated and untreated essential hypertension.

Quereda C, Orte L, Sabater J, Navarro-Antolin J, Villafruela JJ, Ortuño J.

J Am Soc Nephrol. 1996 Jul;7(7):1058-65.

20.

[Fixed combinations of antihypertensive drugs].

Pascual J, Orte L.

Med Clin (Barc). 1996 Apr 13;106(14):558. Spanish. No abstract available.

PMID:
8656752

Supplemental Content

Loading ...
Support Center